Viewing StudyNCT00411099



Ignite Creation Date: 2024-05-05 @ 5:14 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00411099
Status: COMPLETED
Last Update Posted: 2020-12-23
First Post: 2006-12-11

Brief Title: Efficacy Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Major Depressive Disorder
Keywords:
Name View
agomelatine major depressive disorder MDD depression View